The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study

Aims People with diabetes and poor glycaemic control are at higher risk of diabetes‐related complications and incur higher healthcare costs. An understanding of the sociodemographic and clinical characteristics associated with poor glycaemic control is needed to overcome the barriers to achieving ca...

Full description

Saved in:
Bibliographic Details
Published inDiabetic medicine Vol. 33; no. 11; pp. 1499 - 1507
Main Authors McBrien, K. A., Manns, B. J., Hemmelgarn, B. R., Weaver, R., Edwards, A. L., Ivers, N., Rabi, D., Lewanczuk, R., Braun, T., Naugler, C., Campbell, D., Saad, N., Tonelli, M.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.11.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims People with diabetes and poor glycaemic control are at higher risk of diabetes‐related complications and incur higher healthcare costs. An understanding of the sociodemographic and clinical characteristics associated with poor glycaemic control is needed to overcome the barriers to achieving care goals in this population. Methods We used linked administrative and laboratory data to create a provincial cohort of adults with prevalent diabetes, and a measure of HbA1c that occurred at least 1 year following the date of diagnosis. The primary outcome was poor glycaemic control, defined as at least two consecutive HbA1c measurements ≥ 86 mmol/mol (10%), not including the index measurement, spanning a minimum of 90 days. We used multivariable Cox proportional hazards models to evaluate the association between baseline sociodemographic and clinical factors and poor glycaemic control. Results In this population‐based cohort of 169 890 people, younger age was significantly associated with sustained poor glycaemic control, with a hazard ratio (HR) of 3.08, 95% CI (2.79–3.39) for age 18–39 years compared with age ≥ 75 years. Longer duration of diabetes, First Nations status, lower neighbourhood income quintile, history of substance abuse, mood disorder, cardiovascular disease, albuminuria and high LDL cholesterol were also associated with poor glycaemic control. Conclusions Although our results may be limited by the observational nature of the study, the large geographically defined sample size, longitudinal design and robust definition of poor glycaemic control are important strengths. These findings demonstrate the complexity associated with poor glycaemic control and indicate a need for tailored interventions. What's new? We used linked laboratory and administrative data for a large geographically defined cohort of over 160 000 people with diabetes to determine the association between sociodemographic and clinical characteristics and poor glycaemic control, defined as sustained HbA1c ≥ 86 mmol/mol (10%). We used a longitudinal study design with up to 8 years of follow‐up. We found that younger age was the strongest predictor of poor glycaemic control. Other sociodemographic factors (First Nations status and low socio‐economic status), psychiatric disorders and clinical factors including cardiovascular disease, albuminuria and dyslipidaemia were also associated with the outcome of poor glycaemic control.
Bibliography:Figure S1. Details of cohort selection. Figure S2. Adjusted hazard ratios for the time-dependent effect of baseline HbA1c on poor glycaemic control, HbA1c ≥ 86 mmol/mol (10%) for at least 90 days, by period after index date (from the full survival model, including all covariates included in Fig. ). Table S1. Adjusted hazard ratios for sustained poor glycaemic control [HbA1c ≥ 86 mmol/mol (10%) for at least 90 days] for overall cohort and subgroups.
istex:7472FC59703231C2C6557EF2E19BA1406B9CFA44
ark:/67375/WNG-CX1FS7WM-1
ArticleID:DME13023
Alberta Innovates - Health Solutions
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0742-3071
1464-5491
DOI:10.1111/dme.13023